ストックスクリーナーアプリを入手
1.855
2.12%
-0.035
前日終値:
$1.89
開ける：
$1.92
24時間の取引高:
347.52K
Relative Volume:
0.33
時価総額：
$78.92M
収益：
-
当期純損益:
$-40.92M
株価収益率:
-1.0806
EPS:
-1.7167
ネットキャッシュフロー:
$-26.53M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
-18.86%
6か月 パフォーマンス:
-56.98%
1年 パフォーマンス:
-42.37%
1日の値動き範囲:
$1.84
$1.95
1週間の範囲:
$1.78
$2.065
52週間の値動き範囲:
$1.5407
$5.50
Annovis Bio Inc Stock (ANVS) Company Profile
名前
Annovis Bio Inc
セクター
電話
484-875-3192
住所
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Compare ANVS vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
1.855 | 80.40M | 0 | -40.92M | -26.53M | -1.7167 |
VRTX
Vertex Pharmaceuticals Inc
|
446.32 | 113.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
621.97 | 66.62B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
885.24 | 55.43B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.96 | 40.46B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
149.53 | 31.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2024-10-25 | アップグレード | Maxim Group | Hold → Buy |
| 2023-12-29 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
Annovis Bio Inc (ANVS) 最新ニュース
Annovis Bio Price, ANVS Price, Live Charts, and Marketcap - Coinbase
Annovis Regains NYSE Compliance Ahead of Listing Deadline - MyChesCo
Top Annovis Bio (ANVS) Competitors 2026 - MarketBeat
Maxim Group Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Annovis Bio (ANVS) Faces Selling Pressure: Key Levels in Focus After 7.6% DeclineVolume Rate Change - thelegaladvocate.com
Annovis Bio regains NYSE listing compliance - MSN
Annovis Bio regains NYSE listing compliance By Investing.com - Investing.com Nigeria
Annovis Bio Regains NYSE Listing Compliance - The Manila Times
Annovis launches proposed public stock and warrant offering - MSN
Annovis Bio Analyst Ratings and Price Targets | NYSE:ANVS - Benzinga
Annovis Bio director Michael Hoffman buys $142,778 in shares By Investing.com - Investing.com Australia
Annovis Bio director Michael Hoffman buys $142,778 in shares - Investing.com UK
3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced - Moomoo
Annovis Bio (ANVS) Rebounds 5.39%, Tests Key Resistance After Broader Market Upward MomentumCorrective Wave - thelegaladvocate.com
Director Michael Hoffman adds 76,344 Annovis Bio (ANVS) shares in open-market buys - Stock Titan
Annovis Bio prices $15 million public offering at $1.90 - Investing.com UK
Annovis Bio Announces Dilutive Equity Offering for Trials - TipRanks
Annovis Bio Launches ~$15 Million Stock-and-Warrant Offering Underwritten by Canaccord Genuity - TradingView
Annovis Bio (NYSE: ANVS) prices $15M common stock and warrant offering - Stock Titan
Annovis Bio (NYSE: ANVS) raises $13.8M via 7.895M-share offering and warrants - Stock Titan
Annovis Bio Prices $15 Million Public Offering to Fund Neurodegenerative Disease Trials - MEXC
Annovis Bio slips after pricing $15M equity offering - MSN
Annovis announces pricing of $15.0 million public offering of common stock and accompanying warrants - marketscreener.com
Annovis Bio prices $15 million public offering at $1.90 By Investing.com - Investing.com South Africa
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Press Release: Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Annovis Bio Launches Proposed Stock, Warrant Offering; Shares Fall - Moomoo
Annovis Bio stock tumbles on public offering announcement By Investing.com - Investing.com India
Annovis Bio announces public offering of stock and warrants By Investing.com - Investing.com South Africa
Annovis Bio (ANVS) registers equity units with detachable warrants in shelf supplement - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Annovis Bio stock tumbles on public offering announcement - Investing.com
Annovis Bio Inc (ANVS) 財務データ
収益
当期純利益
現金流量
EPS
Annovis Bio Inc (ANVS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hoffman Michael B | Director |
Apr 02 '26 |
Buy |
2.10 |
713,800 |
1,498,980 |
3,288,539 |
0.16%
1.10%
大文字化:
|
ボリューム (24 時間):